Literature DB >> 12432342

Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities.

Elena S Tasheva1, Anja Koester, Avelina Q Paulsen, Alexander S Garrett, Dan L Boyle, Harriet J Davidson, Min Song, Niles Fox, Gary W Conrad.   

Abstract

PURPOSE: To study the role of mimecan, a member of the small leucine-rich proteoglycans (SLRPs) gene family and one of the major components of the cornea and other connective tissues, mice that lack a functional mimecan gene were generated and characterized.
METHODS: Mimecan-deficient mice were generated by gene-targeting using standard techniques. Mice were genotyped by Southern blot analysis. The absence of mimecan transcripts was confirmed by Northern blot analysis. Corneal clarity was examined by slit lamp biomicroscopy. The strength of the skin was evaluated using a biomechanical skin fragility test. Collagen morphology in cornea and skin preparations from mimecan-null and control wild-type mice was analyzed by transmission electron microscopy. The diameter of collagen fibrils in these tissues was determined by morphometric analysis.
RESULTS: Mice lacking mimecan appear to develop normally, are viable and fertile. In a controlled laboratory environment they do not display an evident pathological phenotype compared to wild type mice. Examination of corneal clarity and measurements of corneal thickness show no significant changes in the cornea. However, a skin fragility test revealed a moderate reduction in the tensile strength of skin from mutant mice. Ultrastructural analyses show, on average, thicker collagen fibrils in both corneal and skin preparations from mimecan-null mice. Collagen fibrils from the cornea of mutant mice show an average diameter of 31.84+/-0.322 nm, versus 22.40+/-0.296 nm in their wild type litter-mates. The most pronounced increase in collagen fibril diameter was found in the skin of mimecan-null mice, who demonstrated an average diameter of 130.33+/-1.769 nm, versus 78.82+/-1.157 nm in the wild type mice. In addition, size variability and altered collagen morphology was detected in dorsal and tail skin preparations from the mutant mice.
CONCLUSIONS: The results of the present study demonstrate that mimecan, similar to other members of the SLRP gene family, has a role in regulating collagen fibrillogenesis in vivo. Further studies, such as functional challenges, an evaluation of potential compensation by other proteins (including members of the SLRP family), and generation of double-knockouts will be necessary to fully uncover physiological functions of mimecan in mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432342

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  53 in total

1.  The mechanism of mimecan transcription induced by glucocorticoid in pituitary corticotroph cells.

Authors:  Xiao Na Zhang; Li Qiong Xue; He Jiang; Shao Ying Yang; Huai Dong Song; Qin Yun Ma
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

Review 3.  The transparent lens and cornea in the mouse and zebra fish eye.

Authors:  Teri M S Greiling; John I Clark
Journal:  Semin Cell Dev Biol       Date:  2007-10-30       Impact factor: 7.727

4.  Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan.

Authors:  Guiyun Zhang; Shoujun Chen; Silvia Goldoni; Bennett W Calder; Holly C Simpson; Rick T Owens; David J McQuillan; Marian F Young; Renato V Iozzo; David E Birk
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

Review 5.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 6.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases.

Authors:  Delana R Hopkins; Sunduz Keles; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2007-05-18       Impact factor: 11.583

7.  Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration.

Authors:  Hui-Jie Zhang; Jing Wang; Hui-Fang Liu; Xiao-Na Zhang; Ming Zhan; Feng-Ling Chen
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

Review 8.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

9.  Candidate gene study to investigate the genetic determinants of normal variation in central corneal thickness.

Authors:  David P Dimasi; Kathryn P Burdon; Alex W Hewitt; Ravi Savarirayan; Paul R Healey; Paul Mitchell; David A Mackey; Jamie E Craig
Journal:  Mol Vis       Date:  2010-03-31       Impact factor: 2.367

10.  The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis.

Authors:  Andreas Kampmann; Borja Fernández; Elisabeth Deindl; Thomas Kubin; Frederic Pipp; Inka Eitenmüller; Imo E Hoefer; Wolfgang Schaper; René Zimmermann
Journal:  Mol Cell Biochem       Date:  2008-11-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.